Alnylam Pharmaceuticals ALNY Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Alnylam Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alnylam Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Alnylam Pharmaceuticals's inventories?
- Alnylam Pharmaceuticals (ALNY) reported inventories of $19.9M in Q2 2026.
- How has Alnylam Pharmaceuticals's inventories changed year-over-year?
- Alnylam Pharmaceuticals's inventories decreased by 72.2% year-over-year, from $71.69M to $19.9M.
- What is the long-term trend for Alnylam Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's inventories has grown at a -17.4% compound annual growth rate (CAGR), from $75.2M to $28.9M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.